-
Advance For Nurse Practitioners Mar 2005
Review
Topics: Adult; Carcinoma in Situ; Female; Gynecology; Humans; Middle Aged; Physical Examination; Pruritus Vulvae; Vulvar Neoplasms
PubMed: 15777042
DOI: No ID Found -
Contact Dermatitis 2004
Topics: Anesthetics, Local; Dermatitis, Allergic Contact; Drug Eruptions; Female; Humans; Middle Aged; Ointments; Perineum; Pruritus Vulvae; Tetracaine; Urinary Catheterization
PubMed: 15606669
DOI: 10.1111/j.0105-1873.2004.0459l.x -
Eastern Mediterranean Health Journal =... Nov 2002We evaluated the main causes of vulvar dermatoses; in 785 patients with a vulvar diseases who visited Ibn Rochd Hospital Centre, Casablanca between January 1991 and...
We evaluated the main causes of vulvar dermatoses; in 785 patients with a vulvar diseases who visited Ibn Rochd Hospital Centre, Casablanca between January 1991 and December 2002. The average age was 31 years (range 2 months to 81 years); 362 patients (41.52%) had vulvar pruritus, 273 patients (34.77%) had warts and 157 (20%) had one or more vulva ulcers. The most common infectious pathology was papillomavirus infection, found in 273 cases (34.77%), followed by vulvovaginal candidiases in 102 cases (12.99 %), syphilitic chancre in 18 cases (2.29%) and herpes genitalis in 17 cases (2.16%). The most common non-infectious pathology was vulvar dermatosis: 259 cases (32.99%); idiopathic pruritus vulvae: 61 cases (7.7%); and tumour-related conditions: 45 cases (5.6%). The frequency of infectious conditions was over 50% and these were generally sexually transmitted infections.
Topics: Academic Medical Centers; Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Causality; Child; Child, Preschool; Female; Humans; Infant; Middle Aged; Morocco; Population Surveillance; Prevalence; Pruritus; Retrospective Studies; Sexually Transmitted Diseases; Skin Diseases; Skin Ulcer; Urban Population; Vulvar Diseases
PubMed: 15568459
DOI: No ID Found -
Australian Family Physician Jul 2004
Topics: Child; Coitus; Female; Household Products; Humans; Infant; Life Style; Pruritus Vulvae; Self Care; Skin Care
PubMed: 15301170
DOI: No ID Found -
Australian Family Physician Jul 2004Vulval itch is common. Patients presenting with this symptom can have a long history involving visits to several general practitioners. Self diagnosis as thrush is... (Review)
Review
BACKGROUND
Vulval itch is common. Patients presenting with this symptom can have a long history involving visits to several general practitioners. Self diagnosis as thrush is common, and inappropriate use of over-the-counter antifungal preparations can lead to further irritation and distress. Excoriation, rubbing, maceration, secondary infection and the effects of topical applications frequently complicate matters.
OBJECTIVE
This article identifies the common causes of vulval itch in adults and children, and highlights key features of the diagnosis and management of these conditions. Vulval pain syndromes are beyond the scope of this article and are therefore not discussed.
DISCUSSION
The cause of vulval itch can often be multifactorial, but with careful assessment, a primary diagnosis can be reached in most cases. A good history requires patience, and gentle direct questioning, as patients often feel uncomfortable discussing their problems and may not disclose self applied remedies. Care should be taken during examination, as vulval rashes may be subtle. All postpubertal patients should have a low vaginal swab to diagnose candidiasis rather than treating empirically.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Child; Dermatitis; Diagnosis, Differential; Family Practice; Female; Genital Diseases, Female; Humans; Lichen Sclerosus et Atrophicus; Pregnancy; Pruritus Vulvae; Psoriasis
PubMed: 15301167
DOI: No ID Found -
The Journal of Reproductive Medicine Mar 2004To study skin diseases and hypersensitivity to female sex hormones in patients with the premenstrual syndrome (PMS).
OBJECTIVE
To study skin diseases and hypersensitivity to female sex hormones in patients with the premenstrual syndrome (PMS).
STUDY DESIGN
Thirty women answered a questionnaire related to PMS and underwent gynecologic, dermatologic and laboratory examinations. Intradermal testing was performed with estradiol valerate, progesterone and placebo. Desensitization treatment was instituted in 15 patients.
RESULTS
Ten patients were diagnosed with PMS and concomitant skin disease, including pruritus vulvae, hyperpigmentation, papular eruption and acne vulgaris (group A). Ten patients diagnosed with PMS but without skin disease served as the first control group (group B). The second control group consisted of 10 healthy women (group C). Immediate and delayed hypersensitivity reactions to sex hormones were observed in all patients with PMS and PMS-related skin diseases (groups A and B) but not in healthy women (group C). Desensitization produced a decrease in PMS symptoms and improvement in the skin disease related to PMS.
CONCLUSION
Skin diseases may be a part of PMS. Demonstration of a delayed allergic reaction tofemale sex hormones may uncover a significant pathogenetic mechanism in patients with recurrent skin disease and PMS.
Topics: Adolescent; Adult; Case-Control Studies; Drug Hypersensitivity; Estradiol; Female; Humans; Intradermal Tests; Israel; Middle Aged; Premenstrual Syndrome; Progesterone; Surveys and Questionnaires
PubMed: 15098889
DOI: No ID Found -
African Journal of Medicine and Medical... Mar 2003To improve counselling information to Nigerian family planning clients, we compared non-menstrual events reported by 248 Norplant users and 214 Uniplant users. Women...
To improve counselling information to Nigerian family planning clients, we compared non-menstrual events reported by 248 Norplant users and 214 Uniplant users. Women using Norplant were significantly older and of higher parity and greater contraceptive experience than Uniplant users. Other admission characteristics of the two groups were similar. The total women-months of use of Norplant was 2,946 (mean 11.9 +/- 0.6 SE) months while that for Uniplant was 2,315 (mean 10.8 +/- 0.2 SE) months. About 36% of Norplant users and 15% of Uniplant users reported non-menstrual adverse events, the commonest ones being pain/itching at the insertion site, unexplained low abdominal pains and clinically diagnosed pelvic inflammatory disease (PID). The numbers of women reporting drug-related adverse events were 61 (24.6%) and 23 (10.8%), respectively, among Norplant and Uniplant users. Drug-related serious adverse events were reported by 3 (1.2%) Norplant users and 5 (2%) Uniplant users. The adverse events leading to Uniplant removal were severe urticaria, breast lumps, pruritus vulvae, headache with raised blood pressure, adnexal pains and ovarian cysts, and static weight while those leading to Norplant removal were breast lump and headache with raised blood pressure. Weight gain was reported by only 7 (3%) of Norplant users. Although of no serious clinical consequences, drug-related adverse events should be added to the counselling information to prospective users.
Topics: Adult; Contraceptive Agents, Female; Device Removal; Drug Implants; Female; Humans; Levonorgestrel; Nigeria; Product Surveillance, Postmarketing; Retrospective Studies
PubMed: 15030062
DOI: No ID Found -
The Journal of Reproductive Medicine Feb 2004To evaluate eventual contact sensitization in 7 patients with plasma cell vulvitis (PCV).
OBJECTIVE
To evaluate eventual contact sensitization in 7 patients with plasma cell vulvitis (PCV).
STUDY DESIGN
Seven women with PCV underwent patch tests with the Italian standard series and with additional batteries of allergens (perfumes, preservatives, emulsifiers, medicaments and corticosteroid series).
RESULTS
One patient experienced a positive reaction t o balsam of Peru and wool alcohol.
CONCLUSION
Patch testing is not normally necessary in the management of PCV. However, when a patient with PCV complains of burning or pruritus after application of topical products, patch tests could prove useful.
Topics: Adult; Allergens; Dermatitis, Allergic Contact; Dyspareunia; Female; Humans; Middle Aged; Patch Tests; Plasma Cells; Pruritus Vulvae; Time Factors; Vulvitis
PubMed: 15018438
DOI: No ID Found -
Anaesthesia Mar 2004
Topics: Adult; Antiemetics; Dexamethasone; Female; Humans; Postoperative Nausea and Vomiting; Pruritus Vulvae
PubMed: 14984543
DOI: 10.1111/j.1365-2044.2004.03696.x -
Der Hautarzt; Zeitschrift Fur... Feb 2004Vulvar lichen sclerosus (LS) is a chronic progressive skin disease of unclear etiology. It is often overlooked in early stages, but progresses to destructive atrophy and... (Comparative Study)
Comparative Study Review
Vulvar lichen sclerosus (LS) is a chronic progressive skin disease of unclear etiology. It is often overlooked in early stages, but progresses to destructive atrophy and is associated with an increased risk of vulvar squamous cell carcinoma. The classical symptoms are pruritus and pain, but they are often not distinctive, so that unclear vulvar problems often lead to a biopsy. The histological picture of early LS is quite different from that of late LS with an atrophic epidermis, markedly sclerotic dermis and stiff dilated vessels. The epidermis in early LS is usually normal with only minor irregularities in the rete pattern. The basement membrane is normal or focally widened, while the edematous dermis has only scattered ectatic vessels. The often dense lichenoid and intraepidermal infiltrate explains the spongiosis and vacuolization of the basal layer keratinocytes. Very early cases may only have a sparse lymphocytic infiltrate and hyper-/parakeratosis of the follicular ostia. Early topical therapy can dampen the progression to atrophic, irreversible LS.
Topics: Adult; Biopsy; Carcinoma, Squamous Cell; Child; Female; Humans; Lichen Sclerosus et Atrophicus; Risk Factors; Skin; Time Factors; Vulva; Vulvar Diseases; Vulvar Lichen Sclerosus; Vulvar Neoplasms
PubMed: 14968326
DOI: 10.1007/s00105-003-0645-8